Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesA combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
Vascular Health and Risk Management, 07/23/09
Wang JG – Dihydropyridine calcium channel blockers, such as amlodipine, and angiotensin receptor blockers, such as valsartan, represent the two antihypertensive drug classes with the strongest supportive data for the prevention of stroke. Therefore, when combination therapy is required, a combination of these two antihypertensive classes represents a logical approach.
Related Articles
Differences Between Ischemic Stroke Subtypes in Vascular Outcomes Support a Distinct Lacunar Ischemic Stroke Arteriopathy. A Prospective, Hospital-Based Study
Stroke, 11/09/09
Relevance Score: 93%
Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation
Evidence-Based Medicine, 10/26/09
Relevance Score: 93%
Ischemic stroke and hyperhomocysteinemia: truth or myth
Acta Neurologica Belgica, 10/21/09
Relevance Score: 93%
Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality
Preventive Medicine, 10/16/09
Relevance Score: 93%
Prevention and management of stroke in very elderly patients
The Lancet Neurology, 10/15/09
Relevance Score: 93%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Vascular Health and Risk Management, 11/30/09
Vernakalant hydrochloride for the treatment of atrial fibrillation
Expert Opinion on Investigational Drugs, 11/30/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/23/09
Low Total and Nonheme Iron Intakes Are Associated with a Greater Risk of Hypertension
The Journal of Nutrition, 11/19/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Improving the use of venous thromboembolism prophylaxis in an Australian teaching hospital
Quality & Safety in Health Care, 11/30/09
The innateness of coronary artery: Vasa vasorum
Medical Hypotheses, 11/30/09
The prognostic impact of general and abdominal obesity in peripheral arterial disease
International Journal of Obesity, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor